Zhaoke Ophthalmology Limited (6622.HK) has a MoatMap StockRank of 12/100 based on Quality (30/100), Value (42/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. Zhaoke Ophthalmology, a Chinese healthcare company, operates in an emerging market and is exposed to the 'Dollar Dominance, EM Strain' theme. Without a clear, unpriced asymmetric macro tailwind and specific qualitative data to confirm its quality compounder status or growth-at-a-reasonable-price characteristics, the 'STRONG_SELL' quantitative signal dictates a REMOVE verdict for our high-conviction fund.